Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
14.26
+3.09 (27.66%)
At close: Apr 28, 2026, 4:00 PM EDT
14.43
+0.17 (1.19%)
Pre-market: Apr 29, 2026, 8:06 AM EDT
Edesa Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
126.71M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Innate Pharma | 10.57M |
| Alpha Cognition | 10.22M |
| Equillium | 4.39M |
| Kazia Therapeutics | 1.27M |
| Cardiff Oncology | 593.00K |
| Connect Biopharma Holdings | 64.00K |
| InflaRx | 34.44K |
EDSA News
- 4 weeks ago - Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit - GlobeNewsWire
- 4 weeks ago - Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment - GlobeNewsWire
- 2 months ago - Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study - GlobeNewsWire
- 2 months ago - Edesa Biotech Reports Fiscal 1st Quarter 2026 Results - GlobeNewsWire
- 4 months ago - Edesa Biotech Reports Fiscal Year 2025 Results - GlobeNewsWire
- 6 months ago - Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewsWire
- 6 months ago - Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study - GlobeNewsWire
- 9 months ago - Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewsWire